Weight and metabolic health
Prediabetes and type 2 diabetes
Prediabetes signals elevated future risk; established diabetes requires glucose and complication management. Type 1 diabetes is a different condition.
Potential benefits explored
Better glucose control and relevant weight management.
Semaglutide and tirzepatide have direct human relevance in selected type 2 diabetes contexts; cagrilintide/semaglutide adds combination research. Prediabetes and diabetes require different interpretations.
Practical interpretation
Monitor glycaemia and cardiovascular/kidney risk. B12 is relevant if deficiency or risk factors exist, not as a glucose-lowering supplement.
Meaningful outcomes: HbA1c, glucose patterns and hypoglycaemia where relevant.
Compare the compounds studied for Prediabetes and type 2 diabetes
Members see the full evidence picture for this condition: every compound studied, graded per condition from strong human evidence through to preclinical-only and negative findings, with human and animal results, risks, combination evidence and cited sources — plus how each compound maps to the research materials we list, with live pricing and stock.
Research reference for laboratory materials only. Not medical advice and not a recommendation for human use. Research cut-off: 30 September 2026.